Article

Genetic polymorphisms of FcGR2B and adalimumab effectiveness in Colombian patients with rheumatoid arthritis. Cases-controls study

2022-09-21

Abstract excerpt

<h4>Background: </h4> Adalimumab is one of the main drugs used in the treatment of rheumatoid arthritis (RA); however, the effectiveness of the drug may be affected by the genetic variability of each patient. This study aims to investigate the therapeutic failure of adalimumab associated to genetic polymorphisms of FcGR2B. Methods A case-control study in Colombian patients diagnosed with RA was carried out. The...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f0fdfd3e-797b-5efd-9faf-1a49eed51a3c
DOI: 10.21203/rs.3.rs-2055868/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms of FcGR2B and adalimumab effectiveness in Colombian patients with rheumatoid arthritis. Cases-controls studyDOI 10.21203/rs.3.rs-2055868/v1Read

FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritis.Semantic proximity Read

A cohort study on deficiency of ADA2 from ChinaSemantic proximity Read

A Cohort Study on Deficiency of ADA2 from China.Semantic proximity Read

Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis.Semantic proximity Read

The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.Semantic proximity Read

The role of genetic variants in FCGR2A on the risk of rheumatoid arthritis in the Han Chinese populationSemantic proximity Read

Haploinsufficiency of A20 caused by heterozygous mutations in the TNFAIP3 gene:A Case SeriesSemantic proximity Read

Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.Semantic proximity Read

Treatment of Chronic Inflammatory Diseases – The Potential of PharmacogeneticsSemantic proximity Read

Impact of FCGR2A rs1801274 and IL-6R rs2228145 polymorphisms on tocilizumab response in the Iranian population with severe COVID-19.Semantic proximity Read

A Prospective Pharmacogenomic Study of Crohn's Disease Patients during Routine Therapy with Anti-TNF-α Drug Adalimumab: Contribution of ATG5, NFKB1, and CRP Genes to Pharmacodynamic Variability.Semantic proximity Read

Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis.Semantic proximity Read